Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation.
Saresella M, Zoia CP, La Rosa F, Bazzini C, Sala G, Grassenis E, Marventano I, Hernis A, Piancone F, Conti E, Sesana S, Re F, Seneci P, Ferrarese C, Clerici M.
Saresella M, et al.
Pharmaceuticals (Basel). 2023 Dec 13;16(12):1725. doi: 10.3390/ph16121725.
Pharmaceuticals (Basel). 2023.
PMID: 38139851
Free PMC article.